000			01540 a2200397 4500
005			20250511221155.0
264		0	_c19910731
008			199107s 0 0 eng d
022			_a0306-3623
024	7		_a10.1016/0306-3623(91)90454-e _2doi
040			_aNLM _beng _cNLM
100	1		_aLonghurst, P A
245	0	0	_aThe ability of insulin treatment to reverse or prevent the changes in urinary bladder function caused by streptozotocin-induced diabetes mellitus. _h[electronic resource]
260			_bGeneral pharmacology _c1991
300			_a305-11 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aBody Weight _xdrug effects
650	0	4	_aDiabetes Mellitus, Experimental _xcomplications
650	0	4	_aElectric Stimulation
650	0	4	_aIn Vitro Techniques
650	0	4	_aInsulin _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMuscle Contraction _xdrug effects
650	0	4	_aMuscle, Smooth _xdrug effects
650	0	4	_aOrgan Size _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Inbred Strains
650	0	4	_aUrinary Bladder Diseases _xdrug therapy
650	0	4	_aUrodynamics _xdrug effects
700	1		_aKauer, J
700	1		_aLevin, R M
773	0		_tGeneral pharmacology _gvol. 22 _gno. 2 _gp. 305-11
856	4	0	_uhttps://doi.org/10.1016/0306-3623(91)90454-e _zAvailable from publisher's website
999			_c2061591 _d2061591